TrialCMAJ open
Assessing the efficacy and safety of hydroxychloroquine as outpatient treatment of COVID-19: a randomized controlled trial.
Ilan Schwartz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
24 papers cite it
pooled itcites it